FDA approves first generic ciprofloxacin injection, USP.(Industry News)

Pharmaceutical Processing, October, 2006

The FDA recently approved several Abbreviated New Drug Applications (ANDAs) for generic versions of Bayer Corporation Pharmaceutical Division's CIPRO I.V., a drug to treat certain bacterial infections.

Ciprofloxacin (sip-row-FLOX-asin) Injection, USP, is indicated for the treatment of infections, including urinary tract infections, lower respiratory tract infections (including pneumonias in hospitalized patients, nosocomial pneumonia), bone and joint infections, complicated intraabdominal infections, skin and skin structure infections, and therapy of patients with fever and neutropenia.

In 2005, according to the online magazine, Drug Topics, CIPRO I.V. Injection was on the top 200 list of highest-selling brand-name drugs in the United States,...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.